Clinical Trial Update: Neoadjuvant Goserelin for Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant goserelin for triple-negative breast cancer is reported, status and results are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Goserelin (Goserelin)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Breast Cancer Triple Negative | Phase 2 | Status: UNKNOWN